GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.43X leverage
Performance
- Low
- ₹1,980
- High
- ₹2,007
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹1,996
- Previous Close₹2,001
- Volume160,656
- 50 DMA₹1,982.59
- 100 DMA₹1,943.11
- 200 DMA₹1,844.89
Investment Returns
- Over 1 Month + 1.67%
- Over 3 Month + 6.87%
- Over 6 Month -10.59%
- Over 1 Year + 35.54%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 55.6
- PEG Ratio
- 0.3
- Market Cap Cr
- 56,152
- P/B Ratio
- 5.9
- Average True Range
- 46.45
- EPS
- 89.11
- Dividend Yield
- 0.3
- MACD Signal
- 22.93
- RSI
- 46.86
- MFI
- 65.71
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,989.80
-10.9
(-0.54%)
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹2,015.26
- 50 Day
- ₹1,982.59
- 100 Day
- ₹1,943.11
- 200 Day
- ₹1,844.89
Resistance and Support
1992.5
- R3 2,031.80
- R2 2,019.60
- R1 2,004.70
- S1 1,977.60
- S2 1,965.40
- S3 1,950.50
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,989 As on 20 January, 2026 | 04:40
The Market Cap of Glenmark Pharmaceuticals is ₹56152.3 Cr As on 20 January, 2026 | 04:40
The P/E ratio of Glenmark Pharmaceuticals is 55.6 As on 20 January, 2026 | 04:40
The PB ratio of Glenmark Pharmaceuticals is 5.9 As on 20 January, 2026 | 04:40
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.